BPC-157 vs GHK-Cu
Side-by-side comparison of BPC-157, GHK-Cu — mechanism, dosing, half-life, side effects, and research status.
| Attribute | BPC-157 Body Protection Compound-157 Recovery | GHK-Cu Glycyl-L-Histidyl-L-Lysine Copper Complex Recovery |
|---|---|---|
| Basics | ||
| Molecular type | Gastric Pentadecapeptide | Copper-Binding Tripeptide |
| Amino acids | 15 | 3 |
| Molecular weight | 1,419.5 Da | 340.4 Da |
| Half-life | ~4 hrs (SC) | Short (minutes to hours) |
| Route(s) | Subcutaneous, Intramuscular, Oral (research only) | Subcutaneous, Topical (skin), IV (research) |
| Mechanism & Research | ||
| Primary mechanism | BPC-157 exerts its primary effects through upregulation of the nitric oxide (NO) signalling pathway. By promoting NO synthase activity, it drives vasodilation and angiogenesis at injury sites, accelerating the delivery o… | GHK-Cu forms a stable complex with copper(II), which is essential for its biological activity. The copper complex activates collagenase and other metalloproteinases that remodel damaged extracellular matrix while simulta… |
| Research status | Research Compound | Research Compound |
| Evidence summary | The majority of BPC-157 research is preclinical (animal and in vitro). No large-scale randomised controlled trials in humans have been published as of 2026. The FDA's 2024 assessment noted insufficient human safety and e… | GHK-Cu is one of the most thoroughly researched cosmetic and wound-healing peptides. Topical GHK-Cu is commercially used in skincare. Deeper systemic applications (anti-aging, neuroprotection, systemic collagen support) … |
| Protocol & Dosing | ||
| Typical dose | 200–500 mcg per injection | 1–2 mg/day (SC); topical as needed |
| Frequency | Once or twice daily | Daily |
| Duration | 4–12 weeks | 8–12 weeks |
| Timing | Near injury site when possible | Any time of day |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Prohibited (WADA S0) | Not Prohibited |
| Deeper reading | ||
| Related peptides | TB-500, GHK-Cu, KPV, Pentadeca Arginate | BPC-157, Epithalon, LL-37 |
| Full profile | Read full BPC-157 profile → | Read full GHK-Cu profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.